National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant])
This protocol is for the administration of COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]), by appropriately trained persons, to individuals in accordance with the national COVID-19 vaccination programme.
Source:
Public Health England